Face Cream OEM: Custom Moisturizer Formulation for Private Label Brands

Why Face Cream Decides Whether a Brand Is Taken Seriously

A serum can be a stand-alone hero product. A face cream is the opposite: buyers treat it as the test of whether a brand actually formulates, or simply fills bottles. It is also the highest-value SKU in most skincare ranges, the one customers repurchase most often, and the one that shows up first when someone compares you with an established competitor.

That combination is why private label brands increasingly start with a cream rather than a serum — and why the formulation decisions behind it deserve more attention than a catalogue selection usually gets.

What a Face Cream Actually Is, Formulation-Wise

Strip away the marketing and a face cream is an emulsion: an oil phase dispersed into a water phase (or the reverse), held together by an emulsifier system, thickened to a target texture, preserved, and stabilised so it still looks and feels the same after months on a shelf.

Every cream falls into one of three architectural families:

Choosing the family is not a detail — it sets the skin feel, the preservation strategy, the packaging options and the cost structure at the same time.

Why Creams Fail Silently (And How It Is Prevented)

The defining risk in a cream is time. A cream can pass every check at the factory gate and still separate, thin out, turn grainy or discolour three months later — because its failure modes are physical and chemical, not visible on the production line.

• Phase separation or water weeping — usually an emulsifier system or homogenisation problem, not a problem with the ingredients themselves.
• Graininess developing over time — crystals growing in the oil phase, often driven by temperature cycling during shipping.
• Viscosity drift — the cream thickens or thins as the emulsifier network rearranges.
• Discolouration — oxidation or light exposure, most common in creams carrying sensitive actives.
• Microbial growth — a preservation and packaging problem, not just a preservative problem.

None of these are solved by adding more of an ingredient. They are solved by getting the emulsifier system, the processing parameters — temperature, homogenisation speed, cooling rate — and the packaging right, then proving it with a stability protocol rather than assuming it.

Texture Is a Product Decision, Not a Detail

Texture is the first thing a customer judges, before any active ingredient has had a chance to matter. It should be decided at brief stage, because it dictates the emulsifier system and the process:

• Rich cream — traditional and comforting; the strongest fit for dry or mature positioning.
• Gel-cream — light and quick-absorbing; the default for oily, combination or warm-climate markets.
• Whipped or soufflé texture — aerated and low in density, with strong shelf appeal, but sensitive to process control.
• Balm-to-cream — melts on contact; high perceived value, often anhydrous.
• Overnight cream or sleeping mask — a heavier film, positioned inside a routine rather than as daily wear.

A formulator who asks what it should feel like on the third second is asking the right question. Texture cannot be retrofitted after the emulsion is locked.

Which Actives Actually Survive in a Cream Base?

A cream is a demanding environment for an active ingredient: water, oxygen, heat during processing, and months of storage. Some well-known actives travel through it comfortably; others need special handling or simply perform better in another format.

• Niacinamide, glycerin, panthenol, ceramides and squalane — generally robust and widely used in creams.
• Peptides — workable, but the system has to be checked for compatibility and preservation.
• Hyaluronic acid in different molecular weights — common, though the sensory result depends heavily on grade and concentration.
• Vitamin C derivatives — considerably more stable in a cream than pure L-ascorbic acid, which is difficult to protect inside an emulsion.
• Retinol and similar actives — the hardest case. They demand light-protective packaging, careful process temperature and a stability programme that actually measures degradation over time.

The honest formulation answer is sometimes that an active belongs in a serum or a capsule rather than in a cream. A manufacturer who tells you that is protecting your launch, not losing a sale.

The Jar Problem: Preservation Is a Packaging Decision Too

Wide-mouth jars are the most popular cream packaging — and the riskiest. Every time a customer dips a finger in, the formula is re-inoculated with whatever is on their hands. A preservative system that passes a standard challenge test in a tube can still be marginal in a jar used daily for three months.

This is why the preservation strategy and the packaging decision cannot be made separately. Practical routes:

• Airless pump or tube — the safest choice for sensitive actives and low-preservative positioning.
• Jar with a spatula and a robust preservation system — workable when the formula is designed for it from the start.
• Contact-free dispensing — increasingly requested by brands targeting the premium end.

Testing follows the same logic: a preservative efficacy test (the ISO 11930 framework) plus an accelerated stability programme, ideally run in the packaging you plan to sell rather than in a generic container.

Packaging Choices That Change the Formula

• Airless pump — protects actives, but the formula must be flowable enough to dispense, so viscosity has a ceiling.
• Tube — the best cost-to-protection ratio for most creams.
• Jar — premium perception and a thicker texture, at the cost of preservation pressure.
• Cushion or compact — a distinct format for tinted or touch-up creams; adds development complexity.

Packaging decisions made after the formula is locked are one of the most common causes of a delayed launch. Bring the packaging into the brief.

Compliance by Market: What Changes for a Cream

European Union

Creams are cosmetics under Regulation (EC) No 1223/2009. You need a Responsible Person established in the EU, a Cosmetic Product Safety Report signed by a qualified safety assessor, a Product Information File, and a CPNP notification before the product is placed on the market. Claims must satisfy the common criteria in Regulation (EU) No 655/2013 — and it is claims, more often than ingredients, that get creams withdrawn.

United States

Under MoCRA, facilities that manufacture cosmetic products for US distribution must register with the FDA, products must be listed, serious adverse events reported, and safety substantiated. A cream positioned with drug-style wording — treating a condition rather than improving appearance — moves into drug regulation, which is an entirely different pathway.

China

Cosmetics are governed by the Regulations on the Supervision and Administration of Cosmetics that took effect in 2021. Products are filed by notification or registered depending on category, ingredients must appear in the IECIC inventory, and claims such as brightening or firming fall under the efficacy-claim evaluation requirements. A China-ready cream is normally a separate formulation decision, not a copy of the EU version.

Other markets

The UK runs its own notification route (SCPN), ASEAN markets follow the ASEAN Cosmetic Directive, and Canada, Australia and the Gulf states each add their own labelling layers. Deciding which markets you are launching into before the formula is locked is far cheaper than reformulating afterwards.

MOQ, Sampling and Lead Time

Cream projects sit in the middle of the range: simpler than capsules, more involved than a basic wash-off gel. As an industry reference point rather than a quotation:

• MOQ — commonly in the low thousands of units per SKU for a standard jar or tube, and lower when stock packaging is used.
• Sampling — typically a few weeks for an adjustment to an existing base, and longer for a new emulsion system.
• Stability testing — an accelerated programme usually runs about two to three months; this is the stage brands most often fail to budget time for.
• Bulk production and filling — usually a few weeks after formula approval and packaging arrival.

We will give you actual numbers for your project — based on your formula, packaging and volume — rather than a generic figure.

Building a Cream Range Instead of One Product

The most efficient way to launch is not a single cream but a small, coherent range: a daytime cream, a richer night cream, and often an eye cream or neck cream sharing the same emulsifier platform and fragrance. Sharing a base across SKUs reduces development cost, shortens timelines and makes reordering simpler.

That is also why a cream makes a sensible first order for a new brand: it establishes the formulation platform that the rest of the range can be built on.

Why Brands Manufacture Their Creams With Us

We develop and manufacture private label and custom creams for beauty brands worldwide, including hydrating, brightening and firming-positioned ranges. Formulation, texture development, stability and compatibility testing, packaging sourcing and market documentation are handled under one roof.

• Hydrating Soothing Repair Face Cream OEM/ODM
• Custom Vitamin C Brightening Face Cream OEM/ODM
• Firming Face Cream OEM/ODM Custom Manufacturing
• Whitening Dark Spot Corrector Face Cream OEM/ODM

Start Your Face Cream Project

Tell us your target market, skin-type positioning, texture preference and expected volume, and we will come back with a base recommendation, a realistic unit cost and a timeline you can plan a launch around. We work with brands on private label (your brand on a proven base), OEM/ODM contract manufacturing and full custom formula development — whichever matches where your brand is today.

• Send your brief through our inquiry form — the fastest route to a costed answer.
• Email us at capsulebiotech@163.com.
• Prefer to talk it through? Message the right team on WhatsApp: Capsule Series (capsules only) at +86 158-7655-5319, or Cosmetics Series (serum, hair care, body care, fragrance) at +86 158-7655-5319.

This article is general information for brands planning a cream range. It is not regulatory or legal advice; compliance requirements should be confirmed with a qualified safety assessor or regulatory consultant for each target market.